CONCERT PHARMACEUT


Updates from The Motley Fool

Latest updates on Concert Pharmaceuticals from Fool.com.
3 Biotech Stocks to Buy in March

Why Spark Therapeutics, Albany Molecular Research, and Concert Pharmaceuticals could be great bio...



Stock Performance

View Interactive CNCE Charts
Sponsored by

Key Data Points

Primary metrics and data points about Concert Pharmaceuticals.
Current Price: $16.08
Prev Close: $16.08
Open: $16.24
Bid: $15.75
Ask: $16.95
Day's Range: $16.00 - $17.29
52wk Range: $7.11 - $19.11
Volume: 415,990
Avg Vol 306,150
Market Cap: $359M
P/E (ttm): -7.05
EPS (ttm): ($2.28)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Concert Pharmaceuticals.
CAPS Rating 3 out of 5
 
20 Outperform
2 Underperform
CAPS All Stars
 
4 Outperform
1 Underperform

How do you think Concert Pharmaceuticals will perform against the market?



You pick for Concert Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Concert Pharmaceuticals.

CONCERT PHARMACEUT

  • Exchange: NASDAQ